- Home
- RGS vs ASRT Comparison
RGS vs ASRT Comparison
Compare RGS & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGS
- ASRT
- Stock Information
- Founded
- RGS 1922
- ASRT 1995
- Country
- RGS United States
- ASRT United States
- Employees
- RGS N/A
- ASRT N/A
- Industry
- RGS Other Consumer Services
- ASRT Biotechnology: Pharmaceutical Preparations
- Sector
- RGS Consumer Discretionary
- ASRT Health Care
- Exchange
- RGS Nasdaq
- ASRT Nasdaq
- Market Cap
- RGS 70.8M
- ASRT 73.2M
- IPO Year
- RGS 1991
- ASRT 1997
- Fundamental
- Price
- RGS $27.59
- ASRT $0.86
- Analyst Decision
- RGS
- ASRT Strong Buy
- Analyst Count
- RGS 0
- ASRT 1
- Target Price
- RGS N/A
- ASRT $3.00
- AVG Volume (30 Days)
- RGS 7.7K
- ASRT 539.1K
- Earning Date
- RGS 11-12-2025
- ASRT 11-10-2025
- Dividend Yield
- RGS N/A
- ASRT N/A
- EPS Growth
- RGS 20.05
- ASRT N/A
- EPS
- RGS 45.08
- ASRT N/A
- Revenue
- RGS $223,032,000.00
- ASRT $137,354,000.00
- Revenue This Year
- RGS N/A
- ASRT N/A
- Revenue Next Year
- RGS N/A
- ASRT $4.10
- P/E Ratio
- RGS $0.64
- ASRT N/A
- Revenue Growth
- RGS 13.98
- ASRT 9.22
- 52 Week Low
- RGS $15.00
- ASRT $0.51
- 52 Week High
- RGS $31.50
- ASRT $1.08
- Technical
- Relative Strength Index (RSI)
- RGS 41.33
- ASRT 58.48
- Support Level
- RGS $28.75
- ASRT $0.71
- Resistance Level
- RGS $29.64
- ASRT $0.95
- Average True Range (ATR)
- RGS 0.86
- ASRT 0.05
- MACD
- RGS -0.37
- ASRT 0.01
- Stochastic Oscillator
- RGS 28.57
- ASRT 67.52
About RGS Regis Corporation
Regis Corporation owns, franchises, and operates beauty salons in North America and the U.K., serving mainly price-conscious customers. Its salons, located mostly in strip malls, shopping centers, and Walmart stores, offer services like haircutting, styling, shampooing, conditioning, and hair coloring, along with hair care and beauty products. The company's primary brands include Supercuts, SmartStyle, and Cost Cutters. Regis generates the majority of its revenue from these mass-market locations and reports operations in two segments: franchise and company-owned, with services making up about 94% of company-owned salon sales.
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.